Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report

C Quintana-Ortega, A Remesal… - Modern …, 2021 - academic.oup.com
Anti-melanoma differentiation-associated gene 5 juvenile dermatomyositis (anti-MDA5 JDM)
is associated with high risk of developing rapidly progressive interstitial lung disease (RP …
被引用次数：42 相关文章

Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.

C Quintana-Ortega, A Remesal… - Modern …, 2020 - europepmc.org
Anti-melanoma differentiation-associated gene 5 juvenile dermatomyositis (anti-MDA5 JDM)
is associated with high risk of developing rapidly progressive interstitial lung disease (RP …
[HTML] nih.gov

[HTML][HTML] Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report

C Quintana-Ortega, A Remesal… - Modern …, 2021 - ncbi.nlm.nih.gov
Anti-melanoma differentiation-associated gene 5 juvenile dermatomyositis (anti-MDA5 JDM)
is associated with high risk of developing rapidly progressive interstitial lung disease (RP …

Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report

C Quintana-Ortega, A Remesal… - Modern …, 2021 - Taylor & Francis
Anti-melanoma differentiation-associated gene 5 juvenile dermatomyositis (anti-MDA5 JDM)
is associated with high risk of developing rapidly progressive interstitial lung disease (RP …

Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report

C Quintana-Ortega, A Remesal… - Modern …, 2021 - pubmed.ncbi.nlm.nih.gov
Anti-melanoma differentiation-associated gene 5 juvenile dermatomyositis (anti-MDA5 JDM)
is associated with high risk of developing rapidly progressive interstitial lung disease (RP …

Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.

C Quintana-Ortega, A Remesal… - Modern …, 2021 - search.ebscohost.com
Anti-melanoma differentiation-associated gene 5 juvenile dermatomyositis (anti-MDA5 JDM)
is associated with high risk of developing rapidly progressive interstitial lung disease (RP …